Science & Tech
Four Oral GLP-1R Drugs Compete for Approval, Led by Novo Nordisk: Report
New Delhi, Dec 2 (NationPress) Four oral glucagon-like peptide-1 receptor (GLP1R) drugs, presently in Phase III trials, are vying for regulatory approval, as reported. This development follows the…